Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock

Gary Hattersley, chief scientific officer at Nuvation Bio (NYSE:NUVB), exercised and immediately sold 100,000 shares of Class A common stock in an open-market derivative transaction on October 27, according to an SEC Form 4 filing.Transaction value is based on the SEC Form 4 weighted average purchase price ($5.02).What was the structure and context of this transaction?This transaction involved the exercise of 100,000 stock options, immediately followed by the sale of the resulting shares in the open market.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool